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Abstract
Background: The Bernese Pain Scale for Neonates (BPSN) is a multidimensional pain assessment tool that is already
widely used in clinical settings in the German speaking areas of Europe. Recent findings indicate that pain
responses in preterm neonates are influenced by individual contextual factors, such as gestational age (GA), gender
and the number of painful procedures experienced. Currently, the BPSN does not consider individual contextual
factors. Therefore, the aim of this study is the validation of the BPSN using a large sample of neonates with
different GAs. Furthermore, the influence of individual contextual factors on the variability in pain reactions across
GA groups will be explored. The results will be used for a modification of the BPSN to account for individual
contextual factors in future clinical pain assessment in neonates.
Methods and design: This prospective multisite validation study with a repeated measures design will take place
in three university hospital neonatal intensive care units (NICUs) in Switzerland (Bern, Basel and Zurich). To examine
the impact of GA on pain responses and their variability, the infants will be stratified into six GA groups ranging
from 24 0/7 to 42 0/7. Among preterm infants, 2–5 routine capillary heel sticks within the first 14 days of life, and
among full-term infants, two heel sticks during the first days of life will be documented. For each heel stick,
measurements will be video recorded for each of three phases: baseline, heel stick, and recovery. The infants’ pain
responses will be rated according to the BPSN by five nurses who are blinded as to the number of each heel stick
and as to the measurement phases. Individual contextual factors of interest will be extracted from patient charts.
Discussion: Understanding and considering the influence of individual contextual factors on pain responses in a
revised version of the BPSN will help the clinical staff to more appropriately assess pain in neonates, particularly
preterm neonates hospitalized in NICUs. Pain assessment is a first step toward appropriate and efficient pain
management, which itself is an important factor in later motor and cognitive development in this vulnerable
patient population.
Trial registration: The study is registered in the database of Clinical Trial gov. Study ID-number: NCT 02749461.
Registration date: 12 April 2016.
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Background
In order to ensure their survival, premature born infants
hospitalized in a neonatal intensive care unit (NICU) are
subjected to many painful diagnostic and therapeutic pro-
cedures [1–3]. Although there have been efforts in recent
years to quantify, and most importantly, reduce the num-
ber of procedural exposures to pain in preterm infants,
procedural acute pain remains a challenge in the NICU
setting [3–5]. Often, these treatment interventions take
place during a crucial period in the development of the
nociceptive and central nervous systems [6–8]. There is
more and more alarming evidence that repeated painful
stimuli at this early age may induce both structural and
functional reorganization of the nervous system [7, 9–13]
and result in an altered pain response [14–16]. As a con-
sequence, the motor and cognitive development of prema-
ture infants may be impaired [9, 13, 17–22]. In premature
infants requiring intensive care, the frequency of exposure
to pain and systematic implementation of preventive pain
measures are therefore of key importance for their later
development [4, 5]. Accurate pain measurement is the
first step toward effective pain management.
Pain assessment in neonates
Clinical pain assessment in neonates, particularly those
delivered preterm, is highly challenging [4, 23]. In the
clinical setting, their pain responses have to be observed
and assessed using behavioral and physiological indica-
tors, which can vary across premature infants depending
on their physiological and neurological development
stages [23]. Behavioral indicators used as pain assess-
ment tools include body movements, facial expressions
and crying [24]. Some pain assessments also include be-
havior status indicators, e.g., sleep-wake state [25, 26].
Physiological responses to pain include, for instance,
changes in heart rate, respiratory rate, blood pressure,
oxygen saturation, vagal tone, and peripheral blood flow
[25, 27]. Recently, researchers have begun to investigate
more objective approaches to pain assessment, such as
measurement of heart rate variability, skin conductance
and cortisol as a biomarker of stress [23, 25]. To better
understand and assess neonatal pain responses at cortical
level, newer brain-oriented techniques, such as electroen-
cephalography (EEG) [28, 29] and functional magnetic
resonance imaging (fMRI) [30, 31], are used [11, 32–34].
However, for systematic clinical pain assessment, exclu-
sively observable indicators need to be considered.
Because of the complex nature of pain, multidimen-
sional pain measures that include behavioral and physio-
logical indicators are generally assumed to be most
appropriate for the clinical setting [23]. Although most
infants show both types of pain response indicators, the
correlation between these two indicators is often low
[25, 35]. Moreover, no consistent associations between
behavioral, physiological and cortical measures of pain
have been detected so far [36]. In the face of inconclu-
sive associations between different indicators of pain, the
validity of existing multidimensional tools and their
choices of indicators are currently being questioned,
and, to date, no universally accepted gold standard exists
for neonatal pain assessment [23].
More than 40 pain assessment scales for premature and
full-term infants exist to date [25, 37]. The majority were
designed for research purposes and are inappropriate for
routine clinical procedures (e.g., because they require ex-
tended observation periods) [25, 38]. Furthermore, only a
few have undergone extensive psychometric testing and
are both reliable and valid [25, 39]. Of the pain assessment
scales compiled for clinical application, few have been
validated in premature infants and even fewer consider
individual contextual factors, e.g. gestational age (GA) and
health status [23, 40].
The Bernese pain scale for neonates
The Bernese Pain Scale for Neonates (BPSN; [41]) was
developed by nurses of the University Hospital of Berne
primarily for clinical use. Since its development in 1996,
it has been widely used for bedside pain assessment in
NICUs in the German speaking areas of Europe. Several
hospitals in Switzerland have fully integrated the BPSN
into their daily routine.
The BPSN is a 9-item multidimensional pain assess-
ment tool that includes behavioral and physiological in-
dicators. The instrument consists of seven subjective
(alertness, crying, consolation, skin color, facial expres-
sion, posture, and changes in respiratory rate) and two
physiological (i.e. objective) (changes in heart rate and
oxygen saturation) indicators. Each item is rated on a
four point Likert scale (0, 1, 2, and 3). Higher scores
indicate greater pain-related distress, and a total score of
11 or higher is considered to indicate pain.
In the year 2004, the BPSN was validated to differenti-
ate between pain and non-pain status in neonates be-
tween 27 and 41 weeks of gestation [41]. The results
suggested that the BPSN is a valid and reliable pain as-
sessment instrument for assessing acute pain in term
and preterm neonates. A shortcoming of this first valid-
ation study of the BPSN is the small study population of
12 infants. Furthermore, increasing evidence indicates that
pain reactions of neonates are probably influenced by
more than noxious stimulation alone; individual context-
ual factors might also impact pain reactivity [40, 42–44].
Currently, the BPSN focuses entirely on physiological and
behavioral indicators.
Individual contextual factors
Individual contextual factors encompass individual in-
fant characteristics (e.g., GA, gender, health status, and
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weight), previous pain experience, or the duration of
hospitalization [23, 44]. The variability in pain responses
between and within premature infants as well as the low
association between behavioral and physiological pain
responses may be explained by the influence of individ-
ual contextual factors [35, 42, 45, 46].
Neonatal age is the most commonly examined individ-
ual contextual factor associated with neonatal pain re-
sponse [44]. Premature neonates generally seem more
sensitive to painful stimulation than full-term newborns.
In addition to having low reflex thresholds [47, 48],
newborns lack the inhibitory control that mature brain
structures would exert [49]. As a result, premature neo-
nates display diffuse responses to noxious stimuli rather
than more complex affective reactions [50]. Moreover,
the association between behavioral and physiological
stress responses may differ depending on GA [35]. Al-
though older GA infants displayed a positive association
between the extent of behavioral pain reaction and heart
rate levels, Lucas-Thompson et al. (2008) found no associ-
ation between physiological and behavioral responses in
the youngest GA infants. Despite the high variability in
behavioral and physiologic pain responses in premature
neonates, their responses are less intense [42, 45, 51, 52].
The results of several studies suggest that facial
expression in response to pain increases with GA
[45, 52–55]. This difference is manly influenced by
the older infants’ increased facial expressiveness, which re-
sults from their more developed nervous system and facial
muscles [53, 54]. In contrast, several studies have reported
no significant relationship between GA and facial expres-
sion in response to pain [44, 56]. However, the consider-
ation of reduced facial movement in response to pain in
premature neonates is important. Using pain assessment
scales which rely only on facial expressions may lead clini-
cians to the incorrect conclusion that younger premature
infants do not feel or feel less pain [57]. In addition, the
presence of endotracheal tubes in premature neonates im-
pedes using facial reaction and crying as indicators of pain
because endotracheal tubes are typically secured by taping
them to the skin of the face [52, 54, 57]. Therefore, the
consideration of other behavioral pain indicators encoded
in specific body movements (e.g., hand on face), may pro-
vide further information about pain in premature infants
with extremely low GA [52, 56, 58].
Several studies have examined the influence of previ-
ous pain exposure on reaction to pain, but the findings
do not provide a clear answer [44]. Some studies report
that infants subjected to frequent painful procedures
during their hospitalization display less intense behav-
ioral responses to heel sticks than those who have
undergone fewer procedures [46, 52, 59]. The dampened
pain responses in very premature neonates may be a sign
of exhaustion or a state of passivity resulting from the
numerous procedures they experience during their stay in
a NICU [43, 60, 61]. Contrary to those findings, other
studies suggest that repeated exposure to pain may lead
either to increased pain response (hyperalgesia) or to pain
responses without painful stimulus (allodynia) [15, 62].
Few studies have investigated the influence of other
contextual factors (e.g., gender, health status) on pain
reactions in neonates, and of those that have, the results
are inconsistent [44]. This might be explained by meth-
odological limitations (e.g. the comparison of different
GA groups and the use of a variety of pain assessment
tools) [44]. One challenge in examining the influence of
contextual factors on pain response is the associations
between the individual factors [44]; for example, ex-
tremely low GA infants have a longer stay in a NICU
and are exposed to a higher number of painful proce-
dures than more mature infants. Due to the fact that
contextual factors can lead to underestimation or mis-
judgment of pain severity [54, 63–65], further research is
needed to better understand the factors that influence
pain responses in neonates. Relevant contextual factors
should also be considered in future pain assessment.
Study aims
The aim of this observation study is the validation of the
BPSN, using a large sample of neonates spanning a full
range of GAs. The validation will involve the detection of
the underlying structure of the data and the examination of
the concurrent validity of the BPSN with the Premature
Infant Pain Profile-Revised (PIPP-R; [26]), construct validity,
interrater reliability, specificity and sensitivity. Furthermore,
the variability of pain reactions over time related to behav-
ioral and physiological patterns will be analyzed and the
relationship between behavioral and physiological indicators
examined. In addition, the influence of contextual factors
on the variability of pain reactions across GA groups will be
explored. Finally, the results of this analysis will be used for
modification of the BPSN, to account for individual context-
ual factors in future clinical pain assessment in neonates.
Based on a previous validation study of the BPSN [41],
we hypothesize that the BPSN will be a valid and reliable
pain assessment tool for premature and term infants. In
addition, we expect that the impact of single contextual
factors on infants’ pain reaction will be described and
considered for future pain assessment. In particular, we
anticipate finding a difference in pain reaction depend-
ing on GA. Moreover, we hypothesize that behavioral
and physiological indicators will show low association
across time and that this low association may be ex-
plained by the influence of individual contextual factors.
Methods
This prospective multisite validation study focuses on
psychometric testing of the BPSN and involves repeated
Cignacco et al. BMC Pediatrics  (2017) 17:171 Page 3 of 8
measurement design. The study will take place in three
university hospital NICUs in Switzerland (Basel, Bern
and Zurich).
In total, 150 preterm and healthy-term infants hospi-
talized in a NICU will be included. Consecutive sam-
pling will be used to recruit subjects and the infants will
be stratified according to GA at birth (Fig. 1). Stratifica-
tion is based on the assumption that premature neonates
with a lower GA will show a higher variability in pain
responses, due to their neurological immaturity, than
will premature neonates with a higher GA and full-term
infants [42]. Therefore, larger sample sizes of premature
infants with GAs between 24 0/7 and 29 6/7 weeks
(n = 102) will be included, compared to the samples of
those with GAs between 30 0/7 and 42 0/7 weeks
(n = 48).
Inclusion and exclusion criteria
Premature infants born between 24 0/7 and 36 6/7 weeks
of gestation will be included if they are expected to
undergo 2–5 routine capillary heel sticks during the first
14 days of life. Full-term infants born between 37 0/7
and 42 0/7 weeks of gestation will be included if they
are expected to have at least 2 routine capillary blood
samplings during their first days of life. Furthermore,
signed consent is needed from the infant’s parents, who
have to understand either German or French.
Infants will be excluded if they have suffered a high-
grade intraventricular hemorrhage (grades III and IV), if
they have a severe life-threatening malformation or suffer
from any condition involving partial or total loss of sensi-
tivity, if they have had an arterial cord pH < 7.15, if they
have had surgery for any reason, or if they have a congeni-
tal malformation affecting brain circulation and/or cardio-
vascular system. Infants treated with continuous positive
airway pressure (CPAP) or mechanical ventilation will be
included if they meet the other inclusion and exclusion
criteria.
Recruitment and data collection procedures
In each study center, a trained study assistant will iden-
tify potentially eligible infants and inform the parents
about the study both verbally and via printed informa-
tion material. Interested parents will receive the infor-
mation material and a copy of the informed consent
form to read. A member of the research team will an-
swer any parental questions about the study. No study
procedures will be performed until a signed informed
consent form is obtained from the child’s parents.
After written consent has been received, the neonate
will be videotaped (using a HC-V757 high-definition
camcorder manufactured by Panasonic, Osaka, Japan)
during his or her next 2–5 routine capillary heel sticks.
Before each heel stick procedure, every infant will re-
ceive a dose of 24% oral sucrose (0.2 ml/kg bodyweight)
as a pain relieving intervention in accordance with stan-
dards of care [66]. Video sequences and physiological
variables will be recorded continuously from 2 to 3 min
before the beginning of the heel stick procedure (base-
line phase), through the heel stick (heel stick phase) and
until 2–3 min after the heel stick (recovery phase).
Therefore, three rating sequences will be produced for
each heel stick. The camera operator will begin each
video sequence by focusing on the face of the neonate
for at least one minute to allow adequate assessment of
facial activity and cry. Then, the infant’s body will be
recorded for another minute. For healthy-term infants,
six video sequences per infant will be produced, result-
ing in 96 videos (2 heel sticks * 3 phases * 16 n). For pre-
mature neonates, 2010 video sequences (5 heel sticks * 3
Fig. 1 Stratification of sample according to gestational age (GA) and expected sample numbers (n) (ELGA = extremely low gestational age;
LGA = low gestational age)
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phases * 134 n) will be produced. This will lead to a total
of 2106 video sequences, all of which will be filmed by
trained study collaborators. Each video sequence will be
checked for quality, and digitally elaborated by trained
study assistants using Final Cut Pro X (Apple Inc.,
Cupertino, CA, USA) video editing software. To pre-
serve rater blindness, any information that could indi-
cate the heel stick phase to the raters will be eliminated.
Data quality and completeness of the video sequences
will be controlled continuously by the doctoral student
before uploading each video sequence onto a web-based
rating tool. The web-based rating tool has been devel-
oped specially for the study and includes a randomizing
generator. Uploaded sequences are randomized related
to sequence number, phases and presentation order. Five
trained nurses who are presently working in a NICU and
are experienced users of the BPSN will retrieve the
randomized sequences from the web-based platform and
will rate the behavioral pain reaction by means of the
BPSN and the PIPP-R.
Individual contextual factors will be retrieved retro-
spectively from patient charts by trained study assistants.
All extracted data will be entered into secuTrial®, a web-
based data capture system (InterActive Systems, Berlin,
Germany). Five percent of the patient charts will be
audited by the doctoral student to detect and correct
discrepancies. Emerging questions and inconsistencies
during the overall data collection process will be con-
tinuously discussed to ensure the quality of ongoing data
extraction.
Measures
To establish concurrent validity, neonates’ pain expres-
sion is measured by the BPSN [41] and the PIPP-R [26].
The BPSN measures 9 indicators. The two physiological
indicators will be captured on an ongoing basis from the
neonate’s routine continuous monitoring records (heart
rate and oxygen saturation) during the video recording.
The six subjective indicators (sleeping state, crying,
consolation, skin color, facial expression, posture, and
breathing) will be rated by five independent and blinded
video raters on a 4 point Likert scale. The raters are
blinded towards the phase of the video sequence they
are looking at (baseline, heel stick, and recovery). The
PIPP-R, which is widely used in North America for
assessing acute pain in neonates, measures five indica-
tors of which two are physiological (heart rate and oxy-
gen saturation). The three behavioral indicators (brow
bulge, eye squeeze, and naso-labial furrow) will also be
assessed by the five raters. Each indicator of the PIPP-R
is numerically rated on a Likert scale from 0 to 3 points,
with higher ratings reflecting the rater’s impression of
more intense pain responses. Additionally, the PIPP-R
accounts for GA and baseline behavioral states as
contextual factors. According to the instructions of the
authors, these contextual factors need only be scored if
there are changes in any of the behavioral or physio-
logical items [26]. Neonates with the youngest GAs and
those in quiet sleep receive the highest scores for these
indicators. The PIPP-R scores will be used as a standard
reference in this study.
Based on the findings of a systematic review [44], the
following individual contextual factors will be retrieved
from patient charts: demographic contextual factors,
including GA at birth, gender, birth weight, nationality,
parity and way of delivery; the primary diagnosis and the
most common comorbidities in preterm neonates, includ-
ing bronchopulmonary dysplasia, necrotizing enterocolitis,
respiratory distress syndrome, patent ductus arteriosus,
septic events, cardiac events and respiratory events; the
health status at time of birth measured by the Clinical
Risk Index for Babies (CRIB; [67]). For the time of each
heel stick, the following individual contextual factors will
be retrieved: postnatal age; post-menstrual age (GA at
birth combined with postnatal age); weight; CPAP or
mechanical ventilation at the time of the heel stick pro-
cedure; medication administered (sedatives, opioids, non-
opioids, steroids, caffeine, antibiotics and catecholamines)
from birth and between the recorded heel stick proce-
dures; number of previous painful (e.g., heel stick) and
non-painful (e.g., diaper change) interventions from birth
and between the recorded heel stick procedures (painful
and non-painful interventions were defined in a previous
study [68]); number of painful and non-painful procedures
in the past 24 h; time since the last painful and non-
painful interventions; and, finally, type of last painful
and non-painful interventions. The duration of each
heel stick and the number of additional sucrose doses
given during the heel stick procedures will be regis-
tered while video recording.
Data analyses
Data will be analyzed using SPSS (IBM© SPSS© Statis-
tics Version 23.0, IBM Corp, Armonk, NY, USA) and
Stata (Stata/MP 13.1, StataCorp LP, Lakeway Drive,
USA). Initially, an exploratory analysis will be conducted
to describe the data and uncover any anomalies that
may impact the validity of the data analysis. Methods for
handling missing data will be applied after considering
the volume and pattern of missing data. Descriptive
statistics including measures of central tendency and
dispersion will be used to characterize the individual
variables and to determine the distribution of the data.
Several data analyses will be used for the validation of
the BPSN. An exploratory factor analysis will be per-
formed to analyze the underlying structure of the data.
Cronbach’s Alpha and item-total correlations will be con-
ducted to analyze the reliability of the scale. Furthermore,
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construct validity will be examined by comparing mean
measurements at each of the three rated phases (baseline,
heel stick and recovery). The analysis will be performed
for the total sum score of the BPSN as well as for the
physiological items and the behavioral items alone. In
order to determine the concurrent validity of the BPSN
with the PIPP-R, the total sum scores of the two tools will
be correlated. Intra-class correlation (ICC) will be used to
determine interrater reliability across the 2–5 heel sticks.
To test sensitivity and specificity in the BPSN, a receiver
operating characteristic (ROC) curve analysis will be
performed using the PIPP-R as reference value. Further-
more, the pain and non-pain cut-off values of the two
instruments will be compared.
To explore and depict both temporal variability of pain
reactivity between measurements of each subject, and
variability between corresponding measurements of all sub-
jects, linear mixed modeling will be applied to the behav-
ioral and physiological data on pain reactivity. Additionally,
individual contextual factors will be added to these models
to test for associations with the BPSN scores. As contextual
factors are highly dependent on organizational procedures,
the possible confounding effect of the participating sites will
also be taken into account.
In addition to analyzing the total sum scores of the
BPSN, the separate physiological and behavioral sub-
scores will be tested both against the total scores and
against one another. Pearson correlation will be used as
a descriptive indication of the strength of associations,
while linear mixed modeling will be used to test the
associations themselves.
Sample size and power
The target sample size of 150 neonates is indicated on a
power analysis of the hypothesized association between
the BPSN and GAs at baseline. This analysis is based on
the data from a descriptive-explorative analysis (n = 23)
and a previous study (n = 71; [69]), i.e., assuming an
alpha of 0.05, a beta of 0.80, with at least three baseline
heel sticks conducted per study infant (taking into ac-
count both intra- and inter-infant variability). Because
an attrition rate of 10–15% is anticipated, approximately
170 infants will be enrolled in the study.
Discussion
The BPSN is already widely used in clinical settings in
the German speaking areas of Europe. Pain assessment
with the BPSN requires only two to three minutes of
observation. Despite its practical application, another
advantage of the BPSN is its consideration of various
aspects of behavioral pain responses. Because of less
intense facial reactions in premature neonates and the fre-
quent presence of artificial respiration in this patient popu-
lation, the consideration of various behavioral indicators of
pain may provide further information for appropriate pain
assessment. In addition, the repeated measurement design
in this study will facilitate consideration of the development
of pain responses across time.
The validation of the BPSN on a large sample of neo-
nates with different gestational age and the consider-
ation of the influence of individual contextual factors on
pain reactivity should lead to a higher accuracy of rou-
tine pain assessment. A revised version of the BPSN may
help the clinical staff to prevent and minimize the pain
endured by neonates, particularly preterm neonates in
NICUs. For preterm infants requiring intensive care, ap-
propriate and efficient pain management is an important
factor in later motor and cognitive development. This
study will hopefully contribute to a more accurate pain
assessment tool and to the prevention of negative long-
term outcomes in this vulnerable patient population.
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